This website uses cookies to enhance the user experience.
||
PM

Peter Mollø-Christensen Knudsen1962

Shareholdings
2
9
Norway Business roles
14

Roles

Management

NameRoleTotal operating incomeTotal equityShares
F
FENRIS BIO AS
Managing Director/CEO
-
-628,458
-

Boards

NameRoleTotal operating incomeTotal equityShares
C
C. EMTOR EIENDOM AS
Chairman
886,670
8,928,495
100 %
directly
M
MOFA INVEST AS
Board Member
-
-2,855,104
50 %
indirectly
A
ARNEBRÅTVEIEN 22 AS
Board Member
102,621
-356,253
50 %
indirectly
B
BJØRN FARMANNSGT. 10 AS
Chairman
-
6,415
50 %
indirectly
D
DIOPTER INVEST AS
Board Member
-
56,892
50 %
indirectly
M
MOTLYS AS
Board Member
23,817,068
-
21.45 %
indirectly
Y
YMER MEDIA AS
Board Member
35,377,581
5,015,457
5 %
indirectly
P
PROLYD AS
Board Member
45,216,048
15,229,217
-
T
TÅSENVEIEN 131 AS
Closed
Chairman
-
102,077
-
S
SOGNSVEIEN 110 AS
Closed
Board Member
-
56,356
-
K
KLEIVA GÅRD Peter Mollø-Christensen Knudsen
Holder
-
-
-
F
FENRIS BIO AS
Board Member
-
-628,458
-
S
SPIROX AS
Board Member
576,914
786,275
-
Last update: Aug 28, 2025

Related industries5

Direct relationships5

Shares owned by Peter Mollø-Christensen Knudsen

NameShare classTotal operating incomeTotal equityShare
C
C. EMTOR EIENDOM AS
Ordinære aksjer
886,670
8,928,495
100 %
directly
M
MOFA INVEST AS
0
-2,855,104
50 %
indirectly
A
ARNEBRÅTVEIEN 22 AS
102,621
-356,253
50 %
indirectly
B
BJØRN FARMANNSGT. 10 AS
0
6,415
50 %
indirectly
D
DIOPTER INVEST AS
0
56,892
50 %
indirectly
M
MOTLYS AS
23,817,068
0
21.45 %
indirectly
M
MOTLYS PRODUKSJON AS
9,758,970
0
21.45 %
indirectly
Y
YMER MEDIA AS
35,377,581
5,015,457
5 %
indirectly
A
ALVIRAL AS
Closed
0
-1,569
1.6 %
indirectly
S
SPERMATECH AS
443,352
304,768
1.06 %
indirectly
I
IMMUVERA THERAPEUTICS AS
Ordinære aksjer
220,410
15,816,725
0.02 %
directly 0.02 %
indirectly 1.59 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025